Dr. Langer discusses the difficult challenges of researching and introducing new diabetes drugs for pregnant women with either GDM or type 2, including how to determine if a drug can cross the placenta from mother to fetus (giving us some examples), and the importance of monitoring children for potential long-term effects. He also emphasizes the increasing importance of preventive strategies in the U.S. and the narrow but critical window for effective treatment of pregnant women with diabetes.
More videos with Dr. Langer:
Oded Langer, MD, PhD, Introduction
Pregnancy and the Safety of Oral Diabetes Medications
What Is the Best Test for Blood Glucose Levels in Diabetic Women?
Do Many of Your GDM Patients Become Type 2?
What Do You Want Your A1c to Be?
Dr. Oded Langer, Obstetrician and Gynecologist, is a Professor at Columbia University and specializes in maternal fetal medicine.
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.